Summary. A method is described for the isolation of mg quantities of two forms of rat alpha-fetoprotein (AFP) from amniotic fluid by preparative disc-gel column electrophoresis using a continuous elution system. AFP isolated by this method is suitable for use as an antigen, can be labelled for use in a radioimmunoassay and serves as a reference standard. The characteristics of a new antiserum to AFP are also described.
Introduction
Fetus-specific serum proteins have been found in several mammalian species including man (Gitlin & Boesman, 1967a) . The most predominant of these proteins in the rat is alpha-fetoprotein (AFP) which is second only to albumin in concentration in fetal serum and comprises approximately half of the total protein in amniotic fluid (Stanislawski-Birencwajg, 1967) . The synthesis of AFP in man and rat occurs mainly in the fetal liver and to a lesser extent in rat yolk sac (Gitlin & Boesman, 1967b) . Original investigations of AFP centred on its association with primary hepatomas (see review by Abelev, 1971) , but more recent studies have focused on the association of AFP with abnormal fetal development and fetal compromise in man (see review by Adinolfi, Adinolfi & Lessof, 1975) .
The relationship of AFP to rat ontogenesis was first studied by employing radial immunodiffusion techniques to monitor the levels of AFP in fetal and neonatal serum (Gitlin & Boesman, 1967b) . Subsequent use of radioimmunoassays for rat AFP (Oakes, Sinister & Gold, 1972 ; Sell, 1973a) has (1 ) established ranges of AFP in maternal serum; (2) demonstrated fetal-maternal transfer of radiolabelled AFP; (3) measured clearance rates for AFP in maternal and neonatal serum; and (4) measured concentrations of AFP in fetal and maternal serum and amniotic fluid at term (Watabe, Hirai & Satoh, 1972; Sell, 1973b; Sell & Alexander, 1974; Colquhoun, Gold, Barzell, Oakes & Shuster, 1974) . Further studies on the physiological role of AFP have been inhibited by the lack of techniques for the isolation of significant quantities of this protein.
The objectives of the present study were to isolate mg quantities of rat AFP for use as an antigen for antiserum production and, utilizing a radioimmunoassay system, to establish the normal levels of rat AFP in maternal serum, amniotic fluid, fetal plasma and fetal liver as a function of gestational age.
Materials and Methods

Animals
Nulliparous Sprague-Dawley rats (Canadian Breeding Laboratories, Constant, Quebec) (1956) , were dialysed against 100 ml tris-HCl buffer (30 mM, pH 8-9) for 24 hr at 4°C. This step is reported to lower the salt concentration in the sample to less than 50 mM (Shuster, 1971) . A few drops of sucrose solution (40%) were added to the dialysed amniotic fluid sample to give a final concentration of approximately 5 % sucrose and provide sufficient density for the sample to layer on the surface of an acrylamide gel column. Before placing the amniotic fluid on the gel column a drop of tracking dye (01 % bromophenol blue) was added to the sample.
An LKB Uniphor-7900 preparative electrophoresis system was assembled with a 2-5 30 cm column packed to a height of 10 cm with 7-5 % electrophoresis-grade acrylamide-separating gel (T = 7-7 %, C = 2-6 %). The column was operated at 17 mA and 500 V with an upper buffer of tris-glycine (43 mM, pH 9-3) and a lower buffer of tris-HCl (120 mM, pH 81) at 15°C. Continuous elution was performed for 15 hr with the lower buffer. The eluate, obtained at a rate of 15 ml/hr, was continuously monitored at 254 nm in an LKB Uvicord II recorder and 3 ml fractions were collected.
The protein content in each 3 ml fraction was monitored on a Beckman DB-G Spectrophotometer at 280 nm. Aliquots of each fraction were also analysed for AFP by radioimmunoassay and analytical disc-gel electrophoresis. The analytical electrophoresis system (Buchler Polyanalyst) employed the same buffers and separating gel as described above with the addition of a 2-5 % acrylamide-spacer gel (1-0 0-5 cm;
The system was operated at 4 mA per column at 15°C. Gel columns were stained with 0-5 % Buffalo Blue-Black in 7 % acetic acid for 2 hr and de-stained in two washes of 7 % acetic acid for 24 hr. Pooled AFP-rich fractions were dialysed against two changes of distilled water (2000 ml, 24 (1956) .
Radioimmunoassay of AFP
Purified AFP was labelled with 125I and further purified by two descending chromatography steps as described for the radioimmunoassay of human AFP (Forrester, Hancock, Hay, Lai & Lorscheider, 1975) . The radioimmunoassay used in the present study was, in principle, that described by Sell (1973a) with several modifications. The assay was performed in 10 75 mm glass tubes which contained the following in order of addition: 01 ml 50 mM-phosphate buffer (pH 7-5) containing 0-5% BSA and 001 % sodium azide; 01 ml 50 mM-phosphate buffer (pH 7-5) containing 0-5% boviney-globulin ; 0-1 ml 125I-labelled AFP (1 ·5 10* ct/min ; 0-1 ml of standard AFP or the unknown sample; and in the initial experiments 01 ml 1:400 dilution (phosphate-BSA buffer) of goat anti-rat AFP. The working titre for the antiserum was established by plotting the % radioactivity bound versus the dilution of the antiserum. The optimal titre selected was a point on the curve at which dilution resulted in a significant decrease in % radioactivity bound.
Following incubation of the assay tubes (4°C for 24 hr), 0-5 ml of 25 % (w/v) polyethylene glycol (mol. wt 6000-7500) dissolved in 50 mM-phosphate buffer (pH 7-5) was added to each tube. Polyethyl¬ ene glycol has previously been shown to precipitate -globulin (Desbuquois &Aurbach, 1971 
The antiserum used in the present study was specific for 'fast' and 'slow' AFP and thus the values expressed in the animal experiments represent total AFP. A constant and minimal nonspecific binding of 4-7% was obtained with the radioimmunoassay. Triplicate values for a given level of AFP agreed to within 4 % of each other. It was necessary to dilute the experimental samples in the phosphate-BSA buffer before assay, since a working range of 1 -5-35 ng AFP (15-350 ng/ml) was found to be optimal with the standard curve obtained. The average final dilutions for samples were as follows : serum from non-pregnant rats, undiluted; maternal serum, 1:100; fetal plasma, 1:40,000; amniotic fluid, 1:10,000; fetal liver supernatant, 1:100. The average coefficient of variation for 15 different plasma samples assayed in triplicate on three different standard curves showed an inter-assay precision of 7-8 %. The average coefficient of variation for 15 different plasma samples assayed in triplicate on the same standard curve showed an intra-assay precision of 81 %.
We compared the values obtained for standard curves with our purified reference standard of AFP against the values obtained using standardized ascitic fluid from hepatoma 7777 (Sell, 1973a) . The values obtained using our reference standard were approximately 50 % of those calculated with the hepatoma standard.
Antiserum production
The goat antiserum (1:100 dilution) to rat 'slow' AFP bound the following amounts of 125I-labelled AFP : 89-7 % when no unlabelled AFP was added, 87-9 % with normal rat serum, 42-2 % with purified 'slow' AFP (24 µg), 514% with purified 'fast' AFP (1-5 µg), and 4-7% when no anti-rat AFP was added. Our present working titre for this goat anti-rat AFP is 01 ml of a 1:2000 dilution per assay tube.
Experiments
The levels of AFP in maternal serum, amniotic fluid, fetal plasma and fetal liver as a function of gestational age are given in Table 2 . Peak levels of AFP occurred in the fetal liver and plasma on Day 19 and the overall pattern was similar in both compartments. On Day 20 peak levels of AFP occurred in amniotic fluid and maternal serum preceded by a parallel pattern from Day 11 to 20. After the peak levels, AFP declined but there was a slight rise in maternal serum levels during parturi¬ tion. On Day 20 the ratios of AFP in fetal plasma:amniotic fluid:maternal serum were 75:30:1. After parturition the maternal serum AFP concentration approached 5% of maximum levels within 3 days. From Day 16 of gestation until term there was a tendency for maternal serum levels of AFP to be correlated with litter size; the average daily correlation coefficient was 0-81 (005 <P < 010). Mean of 3 fetuses only.
Discussion
The method described for isolating rat AFP by preparative disc-gel electrophoresis yields mg quan¬ tities of AFP which is free of albumin and other proteins. The heterogeneity of rat AFP demonstrated by isoelectric focusing (Watabe, 1974) is confirmed in that two forms of rat ATP were isolated from each other and from albumin. The predominant AFP in amniotic fluid appears to be the 'slow' form. Isolation of large quantities of 'fast' and 'slow' AFP should readily permit further characterization of their chemical and physiological properties. The amino acid and carbohydrate compositions of both forms appear to be similar (Kerckaert, Bayard, Quiet & Biserte, 1975 Sell (1973b) and Sell & Alexander (1974) . This discrepancy could be explained if the reference standard used by Sell contained some impurities. Our goat anti-rat AFP, which was produced against purified 'slow' AFP, cross-reacts with both forms of AFP, confirming the suggestion that the two forms of AFP possess similar antigenic properties (Kerckaert et al., 1975 Although in the present study in the rat peak levels of AFP in fetal plasma, amniotic fluid and maternal serum were reached at the same stage of gestation, in women the highest level of fetal serum and amniotic fluid AFP are reached early in the second trimester of gestation (Gitlin & Boesman, 1966 ; Rändle & Cumberbatch, 1973) , whilst maternal plasma AFP reaches a peak in the middle of the third trimester (Leek, Ruoss, Kitau & Chard, 1975) .
